Figure 3
Observed effects (efficacy analysis set) of lesogaberan 30, 90, 120 and 240 mg compared with placebo on: (A) the total number of reflux episodes; (B) the number of acid and weakly acid reflux episodes; and (C) the number of pure liquid and mixed liquid/gas reflux episodes. Data are presented as geometric means with 95% confidence intervals.